Testing effectiveness (Phase 2)Ended earlyNCT02587598What this trial is testingStudy of INCB053914 in Subjects With Advanced MalignanciesWho this might be right forSolid Tumors Incyte Corporation 97
Early research (Phase 1)Looking for participantsNCT06224855What this trial is testingDXC006 in Patients With Advanced Solid Tumors and Hematologic MalignanciesWho this might be right forAdvanced Solid TumorsHematological Malignancies Hangzhou DAC Biotechnology Co., Ltd. 280
Early research (Phase 1)Study completedNCT01457417What this trial is testingDKN-01 in Multiple Myeloma or Advanced Solid TumorsWho this might be right forMultiple MyelomaSolid TumorsNon-Small Cell Lung Cancer Leap Therapeutics, Inc. 32
Not applicableLooking for participantsNCT04515810What this trial is testingMobile Health Application (PACT) to Improve Engagement in Advance Care PlanningWho this might be right forLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Hematologic Malignancy+1 more Fred Hutchinson Cancer Center 400
Not applicableLooking for participantsNCT06795815What this trial is testingThe Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic DiseaseWho this might be right forLeukemiaMultiple MielomaAdvanced Solid Tumors+3 more Azienda USL Reggio Emilia - IRCCS 75
Early research (Phase 1)Study completedNCT00004258What this trial is testingEMD 121974 in Treating Patients With Locally Advanced or Metastatic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Indiana University 40
Not applicableNot Yet RecruitingNCT07234630What this trial is testingRole of Fibrinolytic Activity in Neoplastic Pathologies Complicated by CoagulopathyWho this might be right forHematologic NeoplasmsSolid Tumor Metastatic Cancer Advanced CancerDisseminated Intravascular Coagulation University Hospital, Strasbourg, France 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439292What this trial is testingTesting Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 44
Not applicableNo Longer AvailableNCT03420430What this trial is testingExpanded Access to Provide GL-ONC1 for the Treatment of Advanced Cancers With No Standard of CareWho this might be right forAdvanced Stage Cancer (Solid Tumor Disease for 4 Patients)Acute Myeloid Leukemia (6 Patients) Genelux Corporation
Early research (Phase 1)UnknownNCT04481607What this trial is testingEvaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 TabletsWho this might be right forAdvanced Solid Tumor or Hematologic Tumor Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 96
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Ended earlyNCT04214093What this trial is testingAZD0466 in Patients With Advanced Hematologic or Solid TumorsWho this might be right forAdvanced Solid TumorsLymphomaMultiple Myeloma+1 more AstraZeneca 9
Early research (Phase 1)Study completedNCT00465725What this trial is testingA Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+6 more Poniard Pharmaceuticals 18
Large-scale testing (Phase 3)WithdrawnNCT05403580What this trial is testingOlanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced CancerWho this might be right forAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm Mayo Clinic
Testing effectiveness (Phase 2)Active Not RecruitingNCT06385483What this trial is testingTesting Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00082823What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Early research (Phase 1)Study completedNCT02367196What this trial is testingA Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic CancersWho this might be right forHematologic Neoplasms Celgene 60
Early research (Phase 1)Study completedNCT04537715What this trial is testingEffects of Itraconazole and Rifampin on the Blood Tazemetostat LevelsWho this might be right forAll MalignanciesAdvanced MalignanciesHematologic Malignancy+9 more Epizyme, Inc. 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT06357988What this trial is testingTesting GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm+3 more National Cancer Institute (NCI) 34